Parallax Volatility Advisers’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-154,700
Closed -$7.51M 3169
2022
Q4
$7.51M Buy
154,700
+50,500
+48% +$3.17M 0.01% 885
2022
Q3
$7.35M Buy
104,200
+48,500
+87% +$4.15M 0.01% 870
2022
Q2
$3.95M Buy
+55,700
New +$3.59M ﹤0.01% 1059
2020
Q2
Sell
-285,000
Closed -$9.19M 2863
2020
Q1
$9.19M Sell
285,000
-78,800
-22% -$2.66M 0.01% 641
2019
Q4
$12.8M Buy
+363,800
New +$12M 0.01% 571
2019
Q2
Sell
-22,900
Closed -$783K 3673
2019
Q1
$783K Buy
+22,900
New +$810K ﹤0.01% 1371

Other funds holding STAA

Parallax Volatility Advisers's STAA Position: Q1 2023 in Review

Parallax Volatility Advisers sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 79 shares — an estimated $3.83K sold.

Parallax Volatility Advisers first reported a position in STAA in Q4 2017 and held it in 7 quarters. The position peaked at $1.33M in Q4 2019. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Parallax Volatility Advisers reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 79 STAAR Surgical shares in Q1 2023, an estimated $3.83K.
  • Parallax Volatility Advisers first reported a position in STAAR Surgical in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's STAAR Surgical position peaked at $1.33M in Q4 2019.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Parallax Volatility Advisers's 13F filing for Q1 2023, filed 15 May 2023.